Browse Items (9 total)
- Tags: Jadhav Kavita
Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.
Tags: 2019, Chen Xiaoli, Department of Integrative Medical Sciences, Fatty Liver, Hepatology communications, Jadhav Kavita, Kasumov Takhar, Li Yuanyuan, LIPOCALIN, LIVER disease treatment, NEOMED College of Medicine, September 2019 Update, Sun Huihui, Xu Yanyong, Yin Liya, Zhang Yanqiao, Zhu Yingdong
Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis
Tags: 2019, activation, and vascular biology, Arteriosclerosis, Arteriosclerosis, thrombosis, and vascular biology, Atherosclerosis, Cardiovascular System & Cardiology, cholesterol efflux, Department of Integrative Medical Sciences, fatty-acids, FOXA3, gene, Hematology, high-density-lipoprotein, increased, Jadhav Kavita, Li Yuanyuan, Liver, Macrophages, mice lacking, NEOMED College of Medicine, nuclear factor 3-gamma, September 2019 Update, Thrombosis, transport, Xu Yanyong, Yin Liya, Zhang Yanqiao, Zhu Yingdong
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Tags: *Atherosclerosis, *Farnesoid X receptor, *NAFLD, *Obesity, *TGR5, 2018, Adorini Luciano, Animals, Bile Acids and Salts/pharmacology/*therapeutic use, Cytoplasmic and Nuclear/*agonists, Department of Integrative Medical Sciences, Department of Pharmaceutical Sciences, Diet, G-Protein-Coupled/*agonists, Hep G2 Cells, High-Fat/adverse effects, Humans, Hypercholesterolemia/*drug therapy/etiology/metabolism, Inbred C57BL, Jadhav Kavita, Kasumov Takhar, Lee Yoon Kwang, Li Yuanyuan, Male, Mice, Molecular metabolism, NEOMED College of Medicine, NEOMED College of Pharmacy, Non-alcoholic Fatty Liver Disease/*drug therapy/etiology/metabolism, Obesity/*drug therapy/etiology/metabolism, Receptors, Xu Jiesi, Xu Yang, Xu Yanyong, Yin Liya, Zhang Yanqiao, Zhu Yingdong
Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4alpha and Protects Against Alcohol- and MCD diet-induced Liver Injury.
Tags: 2016, Alcoholic/*pathology, Alcohols/*toxicity, Animals, Carboxylic Ester Hydrolases/*metabolism, Chemical and Drug Induced Liver Injury/*pathology, Department of Integrative Medical Sciences, Department of Pharmaceutical Sciences, Diet/*adverse effects, Fatty Liver, Gene Expression Regulation, Genetic, Hepatocyte Nuclear Factor 4/*metabolism, Hepatocytes/metabolism, Humans, Inbred C57BL, Jadhav Kavita, Knockout, Li Yuanyuan, Mice, NEOMED College of Medicine, NEOMED College of Pharmacy, Promoter Regions, Protein Binding, Scientific reports, Xu Jiesi, Xu Yang, Yin Liya, You Min, Zhang Yanqiao
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Tags: *Atherosclerosis, *Farnesoid X receptor, *NAFLD, *Obesity, *TGR5, 2018, Adorini Luciano, Department of Integrative Medical Sciences, Department of Pharmaceutical Sciences, Jadhav Kavita, Kasumov Takhar, Lee Yoon-Kwang, Li Yuanyuan, Molecular metabolism, NEOMED College of Medicine, NEOMED College of Pharmacy, Xu Jiesi, Xu Yang, Xu Yanyong, Yin Liya, Zhang Yanqiao, Zhu Yingdong
Activating transcription factor 3 in immune response and metabolic regulation.
Bile acid receptors in non-alcoholic fatty liver disease.
Tags: 2013, Animals, Bile Acids and Salts/*metabolism, Biochemical pharmacology, Cholesterol, Cytoplasmic and Nuclear/agonists/*metabolism, Fatty Liver/drug therapy/immunology/*metabolism, FXR, G-Protein-Coupled/agonists/*metabolism, Glucose/metabolism, Humans, Inflammation, Jadhav Kavita, Li Yuanyuan, Lipid Metabolism/drug effects, Lipid Regulating Agents/chemistry/pharmacology/therapeutic use, Molecular Structure, Non-alcoholic Fatty Liver Disease, Receptors, TGR5, Triglyceride, Triglycerides/metabolism, Zhang Yanqiao
Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Tags: *Lipid Metabolism, 2016, Adiposity, Animals, Carboxylesterase/*metabolism, Carboxylic Ester Hydrolases/genetics/*metabolism, Department of Integrative Medical Sciences, Department of Pharmaceutical Sciences, Diabetes Mellitus, Diet, Endoplasmic Reticulum Stress, Energy Metabolism, Experimental/enzymology, Gene Knockdown Techniques, Glucose Tolerance Test, Glucose/metabolism, Hepatocyte Nuclear Factor 4/*metabolism, Hepatology (Baltimore, Md.), High-Fat/adverse effects, Homeostasis, Humans, Inbred C57BL, Jadhav Kavita, Kasumov Takhar, Li Yuanyuan, Lipogenesis, Lipolysis, Liver/enzymology, Male, Mice, NEOMED College of Medicine, NEOMED College of Pharmacy, Non-alcoholic Fatty Liver Disease/*etiology/metabolism, Obesity/enzymology/etiology, Sterol Regulatory Element Binding Protein 1/metabolism, Xu Yang, Yin Liya, Zalzala Munaf, Zhang Yanqiao
Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis.
Tags: *Homeostasis, *Lipid Metabolism, 2014, Adorini Luciano, Animals, Carboxylic Ester Hydrolases/*physiology, Chen Wei-Dong, Cholesterol/blood, Cytoplasmic and Nuclear/*physiology, Department of Integrative Medical Sciences, Fatty Acids/metabolism, Ge Xuemei, Hepatology (Baltimore, Md.), Inbred C57BL, Jadhav Kavita, Li Yuanyuan, Lipogenesis, Liver/*enzymology, Mice, NEOMED College of Medicine, Receptors, Sterol Regulatory Element Binding Protein 1/physiology, Triglycerides/metabolism, Xu Jiesi, Xu Yang, Yin Liya, Zhang Yanqiao